Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05454280
PHASE3

Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

Sponsor: Fox Chase Cancer Center

View on ClinicalTrials.gov

Summary

This is a randomized trial of intensified post-discharge surveillance (Intervention Arm) versus standard post-discharge surveillance (Control Arm).

Official title: A Randomized Controlled Trial of Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

880

Start Date

2022-10-14

Completion Date

2028-11-01

Last Updated

2025-07-08

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Intensified post-discharge surveillance

* TCC Nurse Televisit at post-discharge day 1 and 7 * Televisit with APP/Resident/Fellow between post-discharge day 3-5 * Referral for home health nursing evaluation upon discharge

PROCEDURE

Standard post-discharge surveillance

Patients in the Control Arm will receive standard post-discharge surveillance, as deemed appropriate/necessary by the surgeons caring for them at the time of hospital discharge.

Locations (1)

Fox Chase Cancer Center - Philadelphia

Philadelphia, Pennsylvania, United States